Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats
- PMID: 2620186
Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats
Abstract
Dopamine (DA) receptor sensitivity was studied after long-term treatment with haloperidol (0.5 and 3.0 mg/kg, ip, single daily dose) or saline in hypophysectomized and intact rats. Haloperidol treatment for seven days produced a 25 to 125% increase in [3H]-spiroperidol binding to striatal DA receptors in a dose-dependent fashion. The increase in binding sites (Bmax) was similar in both hypophysectomized and intact rats when compared to controls. The present results show that hypophysectomy does not effect the supersensitivity of striatal DA receptors induced by long-term haloperidol treatment.
Similar articles
-
Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat.Biochem Pharmacol. 1986 Oct 15;35(20):3501-6. doi: 10.1016/0006-2952(86)90618-0. Biochem Pharmacol. 1986. PMID: 3768037
-
Hypophysectomy prevents the striatal dopamine receptor supersensitivity produced by chronic haloperidol treatment.Eur J Pharmacol. 1980 Aug 8;65(4):455-6. doi: 10.1016/0014-2999(80)90355-6. Eur J Pharmacol. 1980. PMID: 7408951 No abstract available.
-
Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.Eur J Pharmacol. 1981 Nov 19;76(1):31-6. doi: 10.1016/0014-2999(81)90006-6. Eur J Pharmacol. 1981. PMID: 6119220
-
Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.J Neurochem. 1987 Feb;48(2):516-21. doi: 10.1111/j.1471-4159.1987.tb04123.x. J Neurochem. 1987. PMID: 2878979
-
Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.Res Commun Chem Pathol Pharmacol. 1982 Oct;38(1):21-30. Res Commun Chem Pathol Pharmacol. 1982. PMID: 7146618